720-777-0123
- Your Visit
-
Research & Innovation
It starts with a Q:
For the latest cutting-edge research, innovative collaborations and remarkable discoveries in child health, read stories from across all our areas of study in Q: Advances and Answers in Pediatric Health.
Taymour Hammoudi, MD
- Hematology/Oncology - Pediatric
- Pediatrics
I believe in empowering patients and caregivers by treating them as a whole, providing maximal information possible, leaving no questions unanswered, and adhering to values of honesty, integrity, and humility. I will be fully engaged with you and your caregivers to provide the best possible care.
Get to know Taymour Hammoudi, MD
- Blood and Marrow Transplant
- Cancer Medicine
- Pediatric Cancer
- English
My clinical interests are in providing comprehensive care through transplant and cellular therapy to treat cancer in children and young adults.
Undergraduate 2005
North Carolina State University (NC)
Graduate 2014
Emory University
Graduate 2014
Georgia Institute Of Technology
Medical Education 2014
Emory University School of Medicine
Residency 2017
University of California (San Francisco) School of Medicine Program
Fellowship 2021
University of California (San Francisco) School of Medicine Program
Fellowship 2023
Duke University Hospital Program
For Patients:
My clinical interests are in leveraging patients' existing or transplanted immune system to treat pediatric and young adult cancers. This dovetails with my research interests, which are primarily focused on: (1) profiling and understanding the immune microenvironment of pediatric malignancies; and (2) improving our understanding of how we harness, optimize and drive an augmented immune system after transplant to treat cancer.
My clinical interests are in leveraging patients' existing or transplanted immune system to treat pediatric and young adult cancers. This dovetails with my research interests, which are primarily focused on: (1) profiling and understanding the immune microenvironment of pediatric malignancies; and (2) improving our understanding of how we harness, optimize and drive an augmented immune system after transplant to treat cancer.
For Referring Providers:
My aim as a clinical-translational investigator is to leverage expertise in immunology, cell and tissue engineering and pediatric oncology toward the design and implementation of early and late phase clinical trials centered on cellular and immuno-oncology therapeutics for pediatric and young adult oncology patients so that they may better survive and thrive. My clinical and translational research focuses on developing, implementing and refining stem cell transplant (SCT) and immune effector cell (IEC) therapies in collaboration with basic scientists and translating novel therapeutic strategies that promote optimal immune reconstitution and function for improving relapse-free survival and long term cure for children with malignancies, marrow failure and disorders of immunity (including discovering biomarkers, applying correlative studies, and evaluating outcomes).
My aim as a clinical-translational investigator is to leverage expertise in immunology, cell and tissue engineering and pediatric oncology toward the design and implementation of early and late phase clinical trials centered on cellular and immuno-oncology therapeutics for pediatric and young adult oncology patients so that they may better survive and thrive. My clinical and translational research focuses on developing, implementing and refining stem cell transplant (SCT) and immune effector cell (IEC) therapies in collaboration with basic scientists and translating novel therapeutic strategies that promote optimal immune reconstitution and function for improving relapse-free survival and long term cure for children with malignancies, marrow failure and disorders of immunity (including discovering biomarkers, applying correlative studies, and evaluating outcomes).
